Literature DB >> 599355

Nerve biopsy and conduction studies in diabetic neuropathy.

F Behse, F Buchthal, F Carlsen.   

Abstract

Morphological findings in sural nerves were related to nerve conduction in 12 patients with diabetic neuropathy, five with mainly sensory involvement, four with severe, symmetrical sensory-motor polyneuropathy, and three with multiple mononeuropathy. All had loss of large and small myelinated and of unmyelinated fibres, even early in the disease; segmental remyelination was the most prominent myelin alteration in teased fibres, segmental demyelination was found in only a few fibres. Axonal degeneration and Schwann cell damage seem to proceed independently of each other. The relation between recorded conduction velocity and that expected from the diameter of the largest fibres indicated that slowing of 20 to 30% was due to causes other than fibre loss; a grossly diminished conduction velocity was caused mainly by fibre loss. Electrophysiological findings in the sural nerve were largely representative of findings in other nerves, though abnormalities were less marked in the median nerve. In half the endoneurial vessels from diabetic neuropathy the perivascular space was thickened or contained more layers of basal laminae than normal. The same abnormalities were found in one-quarter of the endoneurial vessels from other acquired neuropathies.

Entities:  

Mesh:

Year:  1977        PMID: 599355      PMCID: PMC492905          DOI: 10.1136/jnnp.40.11.1072

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  25 in total

1.  PATHOLOGICAL OBSERVATIONS ON SIX CASES OF DIABETIC NEUROPATHY.

Authors:  D GREENBAUM; P C RICHARDSON; M V SALMON; H URICH
Journal:  Brain       Date:  1964-06       Impact factor: 13.501

Review 2.  [DIABETIC NEUROPATHIES].

Authors:  A BISCHOFF
Journal:  Praxis       Date:  1965-06-17

3.  SCHWANN-CELL ABNORMALITIES IN DIABETIC NEUROPATHY.

Authors:  P K THOMAS; R G LASCELLES
Journal:  Lancet       Date:  1965-06-26       Impact factor: 79.321

4.  Peripheral nerve conduction in diabetic neuropathy.

Authors:  R W GILLIATT; R G WILLISON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-02       Impact factor: 10.154

5.  Internode length and fibre diameter in developing and regenerating nerves.

Authors:  A D Vizoso; J Z Young
Journal:  J Anat       Date:  1948-04       Impact factor: 2.610

6.  Endoneurial space and its constituents in the sural nerve of patients with neuropathy.

Authors:  F Behse; F Buchthal; F Carlsen; G G Knappeis
Journal:  Brain       Date:  1974-12       Impact factor: 13.501

7.  A reliable staining method for semi-thin sections in experimental neurfanatomy.

Authors:  H Holländer; J L Vaaland
Journal:  Brain Res       Date:  1968-08-26       Impact factor: 3.252

8.  The pathogenesis of sural nerve changes in diabetes mellitus.

Authors:  J S Chopra; L J Hurwitz; D A Montgomery
Journal:  Brain       Date:  1969       Impact factor: 13.501

9.  Peroneal muscular atrophy (PMA) and related disorders. II. Histological findings in sural nerves.

Authors:  F Behse; F Buchthal
Journal:  Brain       Date:  1977-03       Impact factor: 13.501

10.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

View more
  76 in total

1.  The effect of non-enzymatic glycation of serum proteins on their permeation into peripheral nerve in normal and streptozotocin-diabetic rats.

Authors:  N J Patel; V P Misra; P Dandona; P K Thomas
Journal:  Diabetologia       Date:  1991-02       Impact factor: 10.122

2.  Endoneurial capillary abnormalities in mild human diabetic neuropathy.

Authors:  R A Malik; A Veves; E A Masson; A K Sharma; A K Ah-See; W Schady; R H Lye; A J Boulton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

3.  Subclinical diabetic neuropathy: similarities between electrophysiological results of patients with type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P H Hendriksen; P L Oey; G H Wieneke; B Bravenboer; J D Banga
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

Review 4.  Schwann cells as a therapeutic target for peripheral neuropathies.

Authors:  Helmar C Lehmann; Ahmet Höke
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-12       Impact factor: 4.388

5.  L-Arginine supplementation prevents allodynia and hyperalgesia in painful diabetic neuropathic rats by normalizing plasma nitric oxide concentration and increasing plasma agmatine concentration.

Authors:  Lusliany J Rondón; M C Farges; N Davin; B Sion; A M Privat; M P Vasson; A Eschalier; C Courteix
Journal:  Eur J Nutr       Date:  2017-07-19       Impact factor: 5.614

Review 6.  The diabetic leg.

Authors:  J D Ward
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

7.  Acute inflammatory demyelinating polyneuropathy in a diabetic patient: predominance of vesicular disruption in myelin sheaths.

Authors:  C Vital; C Brechenmacher; J P Cardinaud; G Manier; A Vital; B Mora
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

8.  Voltage-dependent calcium currents are enhanced in dorsal root ganglion neurones from the Bio Bred/Worchester diabetic rat.

Authors:  K E Hall; A A Sima; J W Wiley
Journal:  J Physiol       Date:  1995-07-15       Impact factor: 5.182

9.  Evaluation of thermal and pain sensitivity in type I diabetic patients.

Authors:  X Navarro; W R Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

Review 10.  Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab).

Authors:  G J Biessels; V Bril; N A Calcutt; N E Cameron; M A Cotter; R Dobrowsky; E L Feldman; P Fernyhough; J Jakobsen; R A Malik; A P Mizisin; P J Oates; I G Obrosova; R Pop-Busui; J W Russell; A A Sima; M J Stevens; R E Schmidt; S Tesfaye; A Veves; A I Vinik; D E Wright; S Yagihashi; M A Yorek; D Ziegler; D W Zochodne
Journal:  J Peripher Nerv Syst       Date:  2014-06       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.